Pharmaceutical monitoring of a patient with severe ulcerative colitis complicated with extraintestinal manifestations
Objective To analyze the treatment plan of a patient with severe ulcerative colitis complicated with gangrenous pyoderma,knee joint swelling and pain,and ankle joint swelling and pain.Clinical pharmacists assist doctors in formulating medication treatment and monitoring plans to ensure the patient's medication safety,rationality,and effectiveness.Methods Based on the patient's medical history and the effectiveness and adverse reactions of drug treatment,communicate with doctors about the selection,dosage,and principles of drug use,evaluate the risks and benefits of converting the patient's treatment plan from infliximab to tofacitinib,and provide medication education to the patient.Results From a pharmaceutical perspective,clinical pharmacists participated in clinical treatment,optimized drug treatment plans,improved patient awareness and compliance with the disease,and ensured medication safety.Conclusion Clinical pharmacists participate in the formulation of pharmaceutical treatment plans and pharmaceutical monitoring,providing personalized medication services for patients,improving the safety and effectiveness of clinical medication,and enhancing patients'sense of happiness when seeking medical treatment.
InfliximabUlcerative colitisTofatibPyoderma gangrenosumKnee joint swelling and painAnkle joint swelling and pain
万方数据
维普
